[1]赵 玉,张花花.加味白术芍药汤治疗糖尿病胃肠功能紊乱的临床疗效及对其营养状况的影响[J].医学信息,2025,38(01):105-108.[doi:10.3969/j.issn.1006-1959.2025.01.019]
 ZHAO Yu,ZHANG Huahua.Clinical Efficacy of Jiawei Baizhu Shaoyao Decoction in the Treatment of Diabetic Gastrointestinal Dysfunction and its Effect on Nutritional Status[J].Journal of Medical Information,2025,38(01):105-108.[doi:10.3969/j.issn.1006-1959.2025.01.019]
点击复制

加味白术芍药汤治疗糖尿病胃肠功能紊乱的临床疗效及对其营养状况的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年01期
页码:
105-108
栏目:
论著
出版日期:
2025-01-01

文章信息/Info

Title:
Clinical Efficacy of Jiawei Baizhu Shaoyao Decoction in the Treatment of Diabetic Gastrointestinal Dysfunction and its Effect on Nutritional Status
文章编号:
1006-1959(2025)01-0105-04
作者:
赵 玉张花花
西安市高陵区中医医院内分泌肾病科,陕西 西安 710200
Author(s):
ZHAO Yu ZHANG Huahua
Department of Endocrine Nephropathy, Xi′an Gaoling District Hospital of Traditional Chinese Medicine, Xi′an 710200, Shaanxi, China
关键词:
加味白术芍药汤糖尿病胃肠功能紊乱营养状况
Keywords:
Jiawei Baizhu Shaoyao decoction Diabetes mellitus Gastrointestinal dysfunction Nutritional status
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2025.01.019
文献标志码:
A
摘要:
目的 研究加味白术芍药汤治疗糖尿病胃肠功能紊乱的临床疗效及对其营养状况的影响。方法 选取2022年4月-2023年4月在我院诊治的64例糖尿病胃肠功能紊乱患者为研究对象,采用随机数字表法分为对照组和观察组,各组32例。对照组采用常规治疗,观察组在对照组基础上给予加味白术芍药汤治疗,比较两组临床疗效、4 h胃排空率、中医证候积分、胃功能指标[胃动素(MTL)、胃泌素(GAS)]、营养状况指标[白蛋白(ALB)、转铁蛋白(TRF)]、血糖指标[空腹血糖(FBG),餐后2 h血糖(2 h PBG)]。结果 观察组治疗总有效率为96.88%,高于对照组的84.38%(P<0.05);两组治疗后4 h胃排空率均大于治疗前,且观察组大于对照组(P<0.05);两组治疗后中医证候积分均低于治疗前,且观察组低于对照组(P<0.05);两组治疗后MTL均高于治疗前,GAS均低于治疗前,且观察组MTL高于对照组,GAS低于对照组(P<0.05);观察组治疗后ALB、TRF均高于治疗前,且观察组高于对照组(P<0.05),但对照组治疗前后比较,差异无统计学意义(P>0.05);两组治疗后FBG、2 h PBG均低于治疗前,且观察组低于对照组(P<0.05)。结论 加味白术芍药汤治疗糖尿病胃肠功能紊乱的临床疗效确切,可提高治疗总有效率,减轻患者临床症状,改善胃功能和营养状况,促进血糖指标降低,值得临床加以应用。
Abstract:
Objective To study the clinical efficacy of Jiawei Baizhu Shaoyao decoction in the treatment of diabetic gastrointestinal dysfunction and its effect on nutritional status. Methods A total of 64 patients with diabetic gastrointestinal dysfunction diagnosed and treated in our hospital from April 2022 to April 2023 were selected as the research objects. They were divided into control group and observation group by random number table method, with 32 patients in each group. The control group was treated with routine treatment, and the observation group was treated with modified Baizhu Shaoyao decoction on the basis of the control group. The clinical efficacy, 4 h gastric emptying rate, TCM syndrome score, gastric function index [motilin (MTL), gastrin (GAS)], nutritional status index [albumin (ALB), transferrin (TRF)], blood glucose index [fasting blood glucose (FBG), 2 h postprandial blood glucose (2 h PBG)] were compared between the two groups. Results The total effective rate of treatment in the observation group was 96.88%, which was higher than 84.38% in the control group (P<0.05). The gastric emptying rate at 4 h after treatment in the two groups was higher than that before treatment, and that in the observation group was higher than that in the control group (P<0.05). After treatment, the score of TCM syndromes in the two groups was lower than that before treatment, and that in the observation group was lower than that in the control group (P<0.05). After treatment, MTL in the two groups was higher than that before treatment, GAS was lower than that before treatment, while MTL in the observation group was higher than that in the control group, GAS was lower than that in the control group (P<0.05). After treatment, ALB and TRF in the observation group were higher than those before treatment, and those in the observation group were higher than those in the control group (P<0.05), but there was no significant difference in the control group before and after treatment (P>0.05). After treatment, FBG and 2 h PBG in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). Conclusion Jiawei Baizhu Shaoyao decoction has a definite clinical effect in the treatment of diabetic gastrointestinal dysfunction, which can improve the total effective rate of treatment, reduce the clinical symptoms of patients, improve gastric function and nutritional status, and promote the reduction of blood glucose index. It is worthy of clinical application.

参考文献/References:

[1]房霞,管运英,曹虎,等.微生态营养制剂联合参苓白术散治疗老年糖尿病胃肠功能紊乱的效果观察[J].兵团医学,2020,18(3):43-45.[2]王佳,吴浩然.《国际中医药糖尿病诊疗指南》核心内容释义[J].北京中医药,2018,37(8):730-732.[3]唐旭东,王凤云,李慧臻,等.痞满中医临床实践指南(2018)[J].中医杂志,2019,60(17):1520-1530.[4]Angeli TR,O’Grady G.Challenges in defining, diagnosing, and treating diabetic gastroparesis[J].J Diabetes Complications,2018,32(2):127-128.[5]宋锡欣,林继红,庞亚楠,等.糖尿病胃轻瘫116例临床分析[J].医学理论与实践,2019,32(6):820-822.[6]白慧,时高波.四磨汤治疗糖尿病胃轻瘫50例[J].河南中医,2018,38(7):1063-1065.[7]郭珺,窦进,李然伟.温针灸结合半夏泻心汤治疗糖尿病性胃轻瘫[J].国际中医中药杂志,2019,41(5):451-453.[8]姚晓静,马利荣,景录先.柴芩温胆汤加减治疗糖尿病胃轻瘫45例疗效观察[J].中华中医药杂志,2019,34(8):3883-3885.[9]刘方方,马平,邓涛.Hp感染对2型糖尿病患者炎症因子、胃肠激素及胰岛素抵抗的影响[J].国际检验医学杂志,2019,40(4):438-440,444.[10]亢国良,晋绍忠,杨珍俊.双歧杆菌三联活菌胶囊辅助治疗2型糖尿病合并胃肠功能紊乱的效果[J].河南医学研究,2021,30(17):3192-3194.[11]韩洁,孙茜,张伟,等.莫沙必利联合阿格列汀对2型糖尿病合并胃肠功能紊乱的疗效[J].现代消化及介入诊疗,2020,25(9):1217-1220.[12]居永进,刘建璟.运脾汤加减治疗中风后胃肠功能紊乱临床观察[J].云南中医中药杂志,2020,41(9):46-49.[13]徐雪怡,欧小凡,靳晓娟,等.柴芩温胆汤加减对糖尿病性胃轻瘫患者血糖水平、胃肠功能障碍的影响[J].中国实验方剂学杂志,2020,26(18):98-104.[14]白首振.白术芍药散加味方治疗2型糖尿病并发肠功能紊乱性腹泻临床观察[J].中医药临床杂志,2017,29(9):1480-1482.[15]李思,杨元庆,周星娅,等.基于胃肠激素水平变化探讨调理脾胃针法治疗糖尿病性胃轻瘫的疗效机制[J].天津中医药,2021,38(4):474-478.[16]Liew A,Bavanandan S,Prasad N,et al.Asian pacific society of nephrology clinical practice guideline on diabetic kidney disease[J].Nephrology (Carlton),2020,25 Suppl 2:12-45.[17]张彦明,郭丽荣,许建峰.加味香砂六君子汤辨治糖尿病胃轻瘫脾胃虚弱证的临床疗效[J].中国实验方剂学杂志,2021,27(10):64-69.[18]袁涛,赵维纲,曹勇,等.双歧杆菌四联活菌片治疗2型糖尿病患者便秘的有效性及安全性[J].中华内科杂志,2018,57(4):252-257.[19]万生芳,李雅琪,舒畅,等.金芪枳术汤对GK糖尿病胃轻瘫大鼠胃窦组织平滑肌保护和修复作用[J].中国临床药理学杂志,2018,34(19):2327-2330.[20]殷久丽.半夏泻心汤联合甲钴胺治疗糖尿病性胃肠神经病变的疗效[J].实用中西医结合临床,2020,20(6):19-20,32.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
 ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Journal of Medical Information,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
 GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign Tumor and Diabetic Patients[J].Journal of Medical Information,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
 LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
 LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
 XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2018,31(01):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
 ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Journal of Medical Information,2018,31(01):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[7]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
 ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Journal of Medical Information,2018,31(01):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[8]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
 LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(01):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[9]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
 LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[10]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
 LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]

更新日期/Last Update: 1900-01-01